LRCX
61
-4
VRSN
59
-3
XRX
49
-3
DFS
65
-6
KEY
29
-2
WFC
60
-3
AIV
71
4
ICE
59
-3
MSI
50
-8
PHM
57
2
VFC
53
-3
FOXA
63
6
LOW
50
-2
DG
17
-4
EMR
67
2
FMC
39
-4
MAC
65
-2
HIG
48
-6
SLB
39
-3
SBUX
41
-3
LRCX
61
-4
VRSN
59
-3
XRX
49
-3
DFS
65
-6
KEY
29
-2
WFC
60
-3
AIV
71
4
ICE
59
-3
MSI
50
-8
PHM
57
2
VFC
53
-3
FOXA
63
6
LOW
50
-2
DG
17
-4
EMR
67
2
FMC
39
-4
MAC
65
-2
HIG
48
-6
SLB
39
-3
SBUX
41
-3
Financhill
Back

Hikma Pharmaceuticals PLC 10K Form

Sell
48

HKMPY
Hikma Pharmaceuticals PLC

Last Price:
48.85
Seasonality Move:
-0.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HKMPY News And Ratings

See the #1 stock for the next 7 days that we like better than HKMPY

HKMPY Financial Statistics

Sales & Book Value

Annual Sales: $2.88B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $19.88
Price / Book: 0

Profitability

EPS (TTM): 1.70000
Net Income (TTM): $190M
Gross Margin: $1.39B
Return on Equity: 8.69%
Return on Assets: 4.14%

Hikma Pharmaceuticals PLC Earnings Forecast

Key Hikma Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 22 years for HKMPY is 48.35%.
  • The Selling, General & Administrative Expenses for HKMPY have been equal to 22.19% of Gross Profit Margin.
  • The Research & Development expenses have been 5.18% of Revenue.
  • The Interest Expense is 38.42% of Operating Income.
  • The Net Earning history of HKMPY is 6.61% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 13 years.

Hikma Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Current Symbol: HKMPY
Website: hikma.com

Debt

Debt-to-Equity Ratio: 0.51
Current Ratio: 1.57
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HKMPY Technical Analysis vs Fundamental Analysis

Sell
48
Hikma Pharmaceuticals PLC (HKMPY) is a Sell

Is Hikma Pharmaceuticals PLC a Buy or a Sell?